Hennion & Walsh Asset Management’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
RCM
ACA
Hennion & Walsh Asset Management's ASND Position: Q4 2024 in Review
Hennion & Walsh Asset Management sold out of Ascendis Pharma A/S (ASND) in Q4 2024, closing a stake of 6,312 shares — an estimated $942K sold.
Hennion & Walsh Asset Management first reported a position in ASND in Q1 2021 and held it in 13 quarters. The position peaked at $3.91M in Q3 2021. 214 funds tracked by Wall St. Rank hold ASND as of Q4 2024.
- Hennion & Walsh Asset Management reported no remaining Ascendis Pharma A/S position as of Q4 2024 after selling out during the quarter.
- Hennion & Walsh Asset Management sold 6,312 Ascendis Pharma A/S shares in Q4 2024, an estimated $942K.
- Hennion & Walsh Asset Management first reported a position in Ascendis Pharma A/S in Q1 2021 and held it in 13 quarters.
- Hennion & Walsh Asset Management's Ascendis Pharma A/S position peaked at $3.91M in Q3 2021.
- 214 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2024.
Based on Hennion & Walsh Asset Management's 13F filing for Q4 2024, filed 15 Jan 2025.